Cc1cccc(OP(=O)(Nc2c(C)n(C)n(-c3ccccc3)c2=O)Oc2cccc(C)c2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?